A phase 2, double-blind, randomized, placebo controlled trial to assess the efficacy of ABT-436 for alcohol dependence
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2017
Price : $35 *
At a glance
- Drugs ABT 436 (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- 15 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 01 Dec 2014 Planned primary completion date changed from 1 Oct 2014 to 1 Feb 2015 as per ClinicalTrials.gov.
- 01 Dec 2014 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov.